CAT. NO.: AMA-0291
Target Information | |
---|---|
UniProt ID | P14598 |
Product Details | |
---|---|
Size | 100 µL |
Reactivity | Human |
Host | Rabbit |
Source/Isotype | Rabbit IgG |
Storage | Store at -20°C. Do not aliquot the antibody. |
Purification | Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues around Asp217 of human p47phox. |
Usage | |
---|---|
Application | WB |
Product Usage Information Dilution | Western Blotting (1:1000) |
MW (Target) | 47 kDa |
Background | |
---|---|
The phagocytic NADPH oxidase is a multiprotein enzyme that catalyzes the reduction of oxygen to superoxide in response to pathogenic invasion. The NADPH oxidase consists of 6 subunits, including the membrane-bound p91 phox and p22 phox heterodimers (also known as cytochrome b558), the cytosolic complex of p40phox, p47phox and p67phox, and the small GTPase Rac2. Activation of NADPH oxidase is initiated by cytosolic complex phosphorylation, which induces a conformational change that leads to the translocation of the cytosolic complex to the membrane and formation of an active enzyme with cytochrome b558. Defects in p47phox, often resulting from recombination between p47phox and a nearby homologous pseudogene, cause chronic granulomatous disease. Elevated oxidative stress due to increased myocardial NADPH oxidase activity may be a contributing factor in heart failure. |
Our customers have direct access to our experts and give timely feedback to any online inquiries. If you are interested in our products, please contact us.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.